论文部分内容阅读
发病24h内急性心肌梗死(AMI)16例(男14例,女2例;年龄45±11a),在常规治疗基础上加快速静滴尿激酶40-60万U/d×1wk为溶栓组。另与接受常规治疗的14例(男11例,女3例;年龄46±13a)作对照。结果:溶栓组血管再通率显著高于对照组(P<0.01);病死率显著低于对照组(P<0.01);溶栓治疗开始越早越好,发病24h内治疗仍有效,尿激酶以中等剂量为宜。
Intravenous acute myocardial infarction (AMI) within 16 hours of onset (14 males and 2 females; age 45 ± 11a), on the basis of conventional therapy to speed up the rapid intravenous infusion of urokinase 40-60 million U / d × 1wk thrombolytic group . Another with conventional treatment of 14 cases (11 males and 3 females; age 46 ± 13a) as a control. Results: The rate of recanalization in thrombolysis group was significantly higher than that in control group (P <0.01); the mortality rate was significantly lower than that in control group (P <0.01); thrombolytic therapy started earlier and better, A moderate dose of kinase is appropriate.